skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Keep up with events as they unfolded at the 39th Annual J.P. Morgan Annual Healthcare Conference on January 11-14, 2021.

Pharma Intelligence and Insights journalists will bring you real time reporting, highlighting important events and key takeaways from every day of the largest and most informative healthcare investment symposium in the industry. 

Spot new opportunities with an insider’s look at key findings, market trends, challenges, and innovations, as reported by the industry analysts at Pharma Intelligence.

Download Your J.P. Morgan 2021 Preview

 In preparation for the 39th Annual J.P. Morgan Annual Healthcare Conference, we have given you access to a detailed preview covering all the companies to watch for this year.

J.P. Morgan Day 1: Report

Download the highlights & developments from day 1 now to get the insider knowledge on:

  • Amgen CEO On Deals: ‘We Have Deep Pockets, Short Arms’
  • Vertex Is Ready To Spend On Business Development
  • BioMarin Ready To Talk To FDA About Gene Therapy CRL
  • Alnylam Aims For Biotech Big Leagues With Five-Year Strategy
  • Veklury Not Gilead’s Only Highlight, O’Day Says
  • BioNTech And Pfizer Raise 2021 Goal To 2 Billion Vaccine Doses
  • New Merck KGaA CEO Ready To Take Up The COVID Challenge

J.P. Morgan Day 2: Report

Download the highlights from day 2 now to get the headlines shaping the Pharma industry, including:

  • Pfizer CEO Bourla On Drug Pricing Reform
  • What’s Next At Merck & Co., And Its Newco
  • Novartis Changes PD-1 Strategy
  • Sanofi Actively Exploring Gene Therapy BD
  • AbbVie Plans To Grow Without Additional Deals
  • Biogen Partners With Apple In Digital Cognition Study



J.P. Morgan Day 3: Report

Download the highlights from day 3 now to get the headlines shaping the Pharma industry, including: 

  • Teva CEO: Single-Digit Growth Is ‘Reasonable’
  • Relay Prepares SHP2 Drug To Sail With Roche's KRAS G12C Inhibitor
  • UCB Embraces The Digital Age
  • Ionis Confident In Competitive Prospects Of IONIS-TTR-LRx In ATTR
  • Agios Sees Mitapivat Potential Despite Gene Therapy Promise

J.P. Morgan Day 4: Report

Download the highlights from the final day now to get the headlines shaping the Pharma industry, including:

  • A Tailwind From COVID-19
  • Bolt-Ons Remain The Name Of The BD Game
  • BeiGene (BGNE) gives a tour of the company’s explosive growth
  • Ipsen announces a shift to their strategy
  • And more
JPmorgan Day 4

Read also


Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: